THRX
$4.06
Revenue | $0Mn |
Net Profits | $-13.5Mn |
Net Profit Margins | -Inf% |
Theseus Pharmaceuticals Inc’s revenue jumped NaN% since last year same period to $0Mn in the Q3 2023. On a quarterly growth basis, Theseus Pharmaceuticals Inc has generated NaN% jump in its revenue since last 3-months.
Theseus Pharmaceuticals Inc’s net profit jumped 0.28% since last year same period to $-13.5Mn in the Q3 2023. On a quarterly growth basis, Theseus Pharmaceuticals Inc has generated 8.79% jump in its net profits since last 3-months.
Theseus Pharmaceuticals Inc’s net profit margin jumped NaN% since last year same period to -Inf% in the Q3 2023. On a quarterly growth basis, Theseus Pharmaceuticals Inc has generated NaN% jump in its net profit margins since last 3-months.
EPS Estimate Current Quarter | -0.44 |
EPS Estimate Current Year | -0.44 |
Theseus Pharmaceuticals Inc’s earning per share (EPS) estimates for the current quarter stand at -0.44 - a -51.72% fall from last quarter’s estimates.
Theseus Pharmaceuticals Inc’s earning per share (EPS) estimates for the current year stand at -0.44.
Earning Per Share (EPS) | -0.31 |
Theseus Pharmaceuticals Inc’s earning per share (EPS) jumped 18.42% since last year same period to -0.31 in the Q3 2023. This indicates that the Theseus Pharmaceuticals Inc has generated 18.42% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2023-11-17 | -0.36 | -0.31 | 13.89% |
2023-05-11 | -0.42 | -0.34 | 19.05% |
2023-08-10 | -0.36 | -0.34 | 5.56% |